Predictive biomarkers: a paradigm shift towards personalized cancer medicine

October 10, 2011

Predictive biomarkers: a paradigm shift towards personalized cancer medicine.
Nature Reviews – October 2011

La-Thangue-and-Kerr-Nature-Reviews-2011

Share This Post

LinkedInMessengerWhatsApp

More Posts

IngenOx Therapeutics Company Update and Board Reshuffle

May 10, 2024

IngenOx Therapeutics Contributes to Review of Diagnostic Biomarkers for Precision Bowel Cancer Adjuvant Therapy

December 7, 2023

IngenOx Therapeutics Receives Granted Patents from the EU and China for PRMT5 Inhibitor-based Drugs.

October 6, 2023